SCHEMBL5899493

SCHEMBL5899493

CN(CC(=O)c1ccsc1)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.48
TDP1 Q9NUW8 1/20 0.46
ADRB2 P07550 2/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA3 P07451 1/20 0.45
CA4 P22748 1/20 0.45
CA6 P23280 1/20 0.45
CA5A P35218 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
CA13 Q8N1Q1 1/20 0.45
CA14 Q9ULX7 1/20 0.45
CA5B Q9Y2D0 1/20 0.45
KMT2A Q03164 2/20 0.45
MAPT P10636 2/20 0.44
HTT P42858 2/20 0.44
MEN1 O00255 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899593 0.81 KMT2A (0.54) GAATDP1ADRB2CA12CA1
SCHEMBL6402817 0.80 KMT2A (0.58) GAATDP1ADRB2CA12CA1
SCHEMBL5899682 0.78 GAA (0.50) GAATDP1ADRB2CA12CA1
SCHEMBL2335204 0.76 GAA (0.56) GAATDP1ADRB2CA12CA1
SCHEMBL27628054 0.76 TDP1 (0.49) GAATDP1ADRB2CA12CA1
SCHEMBL5899425 0.76 ALDH1A1 (0.56) GAAKMT2AMAPTHTTMEN1
SCHEMBL5899473 0.75 GAA (0.50) GAATDP1ADRB2CA12CA1
SCHEMBL11579297 0.75 POLB (0.64) GAATDP1ADRB2CA12CA1
SCHEMBL15705806 0.72 POLB (0.60) GAATDP1ADRB2CA12CA1
SCHEMBL11580067 0.72 GAA (0.58) GAATDP1ADRB2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 GAA 2422/4885TDP1 689/4885ADRB2 919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.